- Home
- WVE vs DQ Comparison
WVE vs DQ Comparison
Compare WVE & DQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVE
- DQ
- Stock Information
- Founded
- WVE 2012
- DQ 2006
- Country
- WVE Singapore
- DQ China
- Employees
- WVE N/A
- DQ N/A
- Industry
- WVE Biotechnology: Pharmaceutical Preparations
- DQ Semiconductors
- Sector
- WVE Health Care
- DQ Technology
- Exchange
- WVE Nasdaq
- DQ Nasdaq
- Market Cap
- WVE 1.7B
- DQ 1.4B
- IPO Year
- WVE 2015
- DQ 2010
- Fundamental
- Price
- WVE $7.77
- DQ $17.89
- Analyst Decision
- WVE Strong Buy
- DQ Hold
- Analyst Count
- WVE 11
- DQ 5
- Target Price
- WVE $22.00
- DQ $20.31
- AVG Volume (30 Days)
- WVE 1.3M
- DQ 834.2K
- Earning Date
- WVE 03-04-2025
- DQ 04-28-2025
- Dividend Yield
- WVE N/A
- DQ N/A
- EPS Growth
- WVE N/A
- DQ N/A
- EPS
- WVE N/A
- DQ N/A
- Revenue
- WVE $108,302,000.00
- DQ $1,029,080,000.00
- Revenue This Year
- WVE N/A
- DQ N/A
- Revenue Next Year
- WVE $33.28
- DQ $67.31
- P/E Ratio
- WVE N/A
- DQ N/A
- Revenue Growth
- WVE N/A
- DQ N/A
- 52 Week Low
- WVE $4.25
- DQ $13.62
- 52 Week High
- WVE $16.74
- DQ $30.85
- Technical
- Relative Strength Index (RSI)
- WVE 31.26
- DQ 41.28
- Support Level
- WVE $9.43
- DQ $17.70
- Resistance Level
- WVE $10.91
- DQ $18.74
- Average True Range (ATR)
- WVE 0.61
- DQ 0.89
- MACD
- WVE -0.18
- DQ -0.11
- Stochastic Oscillator
- WVE 0.00
- DQ 7.25
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
About DQ DAQO New Energy Corp.
Daqo New Energy Corp is a polysilicon manufacturer based in China. The company manufactures and sells high-purity polysilicon to manufacturers who use it to make ingots, cells, and modules for solar power solutions. The polysilicon is packaged to meet crucible stacking, pulling, and solidification needs. All of the company's revenues come from the People's Republic of China.